At the dated check, the references listed below either did not resolve in
Crossref or DataCite, or carried a retraction notice. Each one is shown with the
registry record that put it there.
The 54 checked references that resolve
resolves10.1016/S0140-6736(18)32779-XRadiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
resolves10.1016/S0140-6736(18)32752-1Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
resolves10.3389/fonc.2017.00129Prognostic Impact of AJCC/UICC 8th Edition New Staging Rules in Oropharyngeal Squamous Cell Carcinoma
resolves10.1016/j.molimm.2018.02.005Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis
resolves10.1158/1078-0432.CCR-19-0211Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
resolves10.1002/ijc.32412Identification of prognostic molecular biomarkers in 157 HPV‐positive and HPV‐negative squamous cell carcinomas of the oropharynx
resolves10.18632/oncotarget.21174Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines
resolves10.1002/lary.26679Barriers to generating PDX models of HPV‐related head and neck cancer
resolves10.1158/0008-5472.CAN-12-4704ALDH1-Positive Cancer Stem Cells Predict Engraftment of Primary Breast Tumors and Are Governed by a Common Stem Cell Program
resolves10.1007/s10549-015-3585-yPrognostic and functional importance of the engraftment-associated genes in the patient-derived xenograft models of triple-negative breast cancers
resolves10.1016/j.celrep.2018.10.004Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma
resolves10.1200/JCO.2016.68.2955Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx
resolves10.1126/science.1206923Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in
<i>NOTCH1</i>
resolves10.1186/gm453Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors
resolves10.1038/nature14129Comprehensive genomic characterization of head and neck squamous cell carcinomas
resolves10.1158/1078-0432.CCR-13-3310Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas
resolves10.1093/annonc/mdv109Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing
resolves10.1002/cncr.30570<i>TRAF3/CYLD</i> mutations identify a distinct subset of human papillomavirus‐associated head and neck squamous cell carcinoma
resolves10.1002/cncr.32068Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus–positive oropharyngeal squamous cell carcinoma
resolves10.1038/nbt.3391Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity
resolves10.1093/hmg/ddu733Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies
resolves10.1002/ijc.30081Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma
resolves10.1073/pnas.1009933108Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming
resolves10.1073/pnas.1310432110Tumor suppressor p16
<sup>INK4A</sup>
is necessary for survival of cervical carcinoma cell lines
resolves10.1158/0008-5472.CAN-13-2479p16INK4a Impairs Homologous Recombination–Mediated DNA Repair in Human Papillomavirus–Positive Head and Neck Tumors
resolves10.3389/fonc.2018.00095CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell Carcinoma
resolves10.1056/NEJMoa1801946Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
resolves10.1126/science.aaa1348Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
resolves10.1186/s13073-015-0219-2Mutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance
resolves10.1084/jem.20110198Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway
resolves10.1016/j.cell.2018.03.022Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
resolves10.1093/nar/gkv468ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
resolves10.1136/jmg.2005.033498Comprehensive analysis of <i>CDKN2A</i> (p16<sup>INK4A</sup>/p14<sup>ARF</sup>) and <i>CDKN2B</i> genes in 53 melanoma index cases considered to be at heightened risk of melanoma
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.